Mediva AS
Score · fiscal year 2025
69of 100
How to read this: the company is ahead of 88 % of companies in the Morning class Small in the same sector in 2025. What does this mean?
Rank in the Morning class Small: 36 of 303 · What are Morning company classes?
Place in the whole sector: 313 of 1,989 · Helse og omsorg
Profile
Lion · Leader
High profitability, high solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 75 and solidity 76 out of 100 among companies in the Morning class Small in the same sector in 2025. Methodology
Against the sector
Mediva AS is 18 points above the median for companies in the Morning class Small in the same sector in 2025.
Median score 51 among 303 companies.
Against companies in the Morning class Small in the same sector in 2025: operating margin 23.2% (median 5.3%) and equity ratio 70.6% (median 38.6%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 10 MNOK | 21 MNOK |
| Operating margin | 23.2% | 5.3% |
| Profit margin | 23.9% | 5.2% |
| Return on assets | 22.8% | 10.2% |
| Equity ratio | 70.6% | 38.6% |
| Debt-to-equity | 0.42 | 1.33 |
| Current ratio | 1.98 | 1.42 |
| Revenue growth | 7.7% | 5.1% |
| Revenue per employee | 1.68 MNOK | 1.03 MNOK |
The median and “ahead of” refer to companies in the Morning class Small in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 69, Mediva AS does better than 88% of companies in the Morning class Small in the same sector (303 companies) in 2025.
Score 2023–2025
- Mediva AS
- Median: companies in the Morning class Small in the same sector
Mediva AS has a score of 69 for 2025, rank 313 of 1,989 in the sector.
Strongest: Solidity: percentile 76 against peers, equity ratio 70.6% against a median of 38.6%. Profitability: percentile 75 against peers, operating margin 23.2% against a median of 5.3%.
No area is clearly below its peers.
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
Mediva AS had an operating margin of 23.2% and an equity ratio of 70.6% in 2025, and ranks 313 of 1,989 in Helse og omsorg.
From 2024 to 2025: the operating margin fell from 28.4% to 23.2% and the equity ratio rose from 65.1% to 70.6%.
This text is generated automatically from the 2025 accounts.
Three simple methods
The methods give between 7 MNOK and 24 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | 18 MNOK |
| EV/EBIT | 8.0 | 24 MNOK |
| P/B | 1.0 | 7 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
No rules were triggered for this year.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 0.2% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
See interest rates, prices and exchange rates for the sector
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2026, the sector's weakest year, for this company.
The sector's weakest year was 2026, with a median operating margin of −10.4%. Based on the 6 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 75 | weight 30% |
|---|---|---|
| Solidity | 76 | weight 25% |
| Liquidity | 64 | weight 15% |
| Growth | 60 | weight 15% |
| Consistency | 57 | weight 15% |
Durability: 67 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is Mediva AS?
The operating margin was 23.2% in 2025, against a median of 5.3% among companies in the Morning class Small in the same sector. Return on assets was 22.8%.
How solid is Mediva AS?
The equity ratio was 70.6% in 2025 (median 38.6%). Debt-to-equity was 0.42 (median 1.33).
What is the liquidity of Mediva AS like?
The current ratio was 1.98 in 2025 (median 1.42).
How does Mediva AS compare in Helse og omsorg?
Mediva AS ranks 313 of 1,989 in Helse og omsorg for 2025. Among companies in the Morning class Small it is number 36 of 303. Revenue changed by 7.7% from the year before.
From the Central Coordinating Register
- Org. no.
- 913439201
- Legal form
- AS
- Sector
- Helse og omsorg (86.993)
- Morning company class
- Small
- Employees
- 6 registered 10 September 2026
- Founded
- 10 March 2014 12 years in operation
- Share capital
- 0.03 MNOK
- Business address
- Grønnegata 10, 9008 TROMSØ
- Municipality
- Tromsø rank 9 of 11 in KOSTRA group 12
- Latest accounts filed
- 2025
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
Loading roles …
Source: Central Coordinating Register, fetched 1 November 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 30 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 68 | 64 | 69 | |
| Rank | 451 | 482 | 313 | |
| Operating margin | 19.6% | 28.4% | 23.2% | |
| Return on assets | 18.4% | 25.9% | 22.8% | |
| Equity ratio | 75.4% | 65.1% | 70.6% | |
| Current ratio | 2.03 | 1.52 | 1.98 | |
| Revenue growth | – | 13.9% | 7.7% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 8.2 MNOK | 9.3 MNOK | 10.1 MNOK |
| Operating profit | 1.6 MNOK | 2.6 MNOK | 2.3 MNOK |
| Profit before tax | 1.6 MNOK | 2.7 MNOK | 2.4 MNOK |
| Net profit | 1.3 MNOK | 2.1 MNOK | 1.8 MNOK |
| Financial expenses | 0.0 MNOK | 0.0 MNOK | 0.0 MNOK |
| Total assets | 8.9 MNOK | 10.5 MNOK | 10.6 MNOK |
| Current assets | 4.4 MNOK | 5.5 MNOK | 6.1 MNOK |
| Equity | 6.7 MNOK | 6.8 MNOK | 7.5 MNOK |
| Retained earnings | 6.7 MNOK | 6.8 MNOK | 7.4 MNOK |
| Total liabilities | 2.2 MNOK | 3.7 MNOK | 3.1 MNOK |
| Current liabilities | 2.2 MNOK | 3.6 MNOK | 3.1 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 30 October 2026, accounts id 6381975.
Further
Similar companies
- Osterøy Tannlegesenter AS index 69, rank 298 · compare
- Borg Medical AS index 69, rank 303 · compare
- Samtun AS index 69, rank 308 · compare
- Dth Derma AS index 69, rank 317 · compare
- Ophthalmos AS index 68, rank 325 · compare